Scott A. Waldman

Also affiliated with Thomas Jefferson University Hospital, Sidney Kimmel Cancer Center, Sidney Kimmel Comprehensive Cancer Center

Biochemistry, Genetics and Molecular BiologyMedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 27 papers. Top paper: “Chimeric Ad5.F35 vector evades anti-adenovirus serotype 5 neutralization opposing GUCY2C-targeted antitumor immunity”.

Chimeric Ad5.F35 vector evades anti-adenovirus serotype 5 neutralization opposing GUCY2C-targeted antitumor immunity

Journal for ImmunoTherapy of Cancer(2020)10.1136/jitc-2020-001046

N/A

0.970DataRank · unranked

38 citations

Jagmohan Singh, Robert D. Carlson, Elinor Leong, Trevor R. Baybutt, Joshua R. Barton +9 more

An update on guanylyl cyclase C in the diagnosis, chemoprevention, and treatment of colorectal cancer

Expert Review of Clinical Pharmacology(2020)10.1080/17512433.2020.1826304

N/A

0DataRank · unranked

10 citations

Scott A. Waldman, Jeffrey A. Rappaport

122 Guanylyl cyclase C as a target for CAR-T cell therapy in a metastatic gastric cancer model

Regular and Young Investigator Award Abstracts(2020)10.1136/jitc-2020-sitc2020.0122

N/A

0DataRank · unranked

2 citations

Trevor R. Baybutt, Megan Weindorfer, Robert D. Carlson, Alicja Zalewski, Scott A. Waldman +2 more

Review article: diagnosis, management and patient perspectives of the spectrum of constipation disorders

Alimentary Pharmacology & Therapeutics(2021)10.1111/apt.16369

N/A

0DataRank · unranked

80 citations

Satish S.C. Rao, Kimberly Kearns, Kimberly Orleck, Scott A. Waldman, Amol Sharma

Guanylyl cyclase 2C (GUCY2C) in gastrointestinal cancers: recent innovations and therapeutic potential

Expert Opinion on Therapeutic Targets(2021)10.1080/14728222.2021.1937124

N/A

0DataRank · unranked

18 citations

Adam E. Snook, Scott A. Waldman, Ariana A. Entezari

GUCY2C as a biomarker to target precision therapies for patients with colorectal cancer

Expert Review of Precision Medicine and Drug Development(2021)10.1080/23808993.2021.1876518

N/A

0DataRank · unranked

16 citations

John C. Flickinger, Babar Bashir, Megan Weindorfer, Sanjna Shelukar, Madison Crutcher +3 more

Stem Cells as Therapeutic Targets in Colorectal Cancer

Personalized Medicine(2021)10.2217/pme-2020-0099

N/A

0DataRank · unranked

14 citations

Adam E. Snook, Scott A. Waldman, Alicja Zalewski

A β-Catenin-TCF-Sensitive Locus Control Region Mediates GUCY2C Ligand Loss in Colorectal Cancer

Cellular and Molecular Gastroenterology and Hepatology(2021)10.1016/j.jcmgh.2021.12.014

N/A

0DataRank · unranked

12 citations

Ariana A. Entezari, Adi Caspi, Signe Caksa, Aakash Jhaveri, Timothy J. Stanek +8 more

The shifting paradigm of colorectal cancer treatment: a look into emerging cancer stem cell-directed therapeutics to lead the charge toward complete remission

Expert Opinion on Biological Therapy(2021)10.1080/14712598.2021.1929167

N/A

0DataRank · unranked

8 citations

Madison Crutcher, Scott A. Waldman, Adam E. Snook, Jessica Kopenhaver

Emerging Targets for the Diagnosis of Parkinson’S Disease: Examination of Systemic Biomarkers

Biomarkers in Medicine(2021)10.2217/bmm-2020-0654

N/A

0DataRank · unranked

7 citations

Adam E. Snook, Scott A. Waldman, Lara Cheslow

Chimeric adenoviral (Ad5.F35) and listeria vector prime-boost immunization is safe and effective for cancer immunotherapy

npj Vaccines(2022)10.1038/s41541-022-00483-z

N/A

0DataRank · unranked

16 citations

Ross E. Staudt, Jagmohan Singh, Robert D. Carlson, Joshua R. Barton, Trevor R. Baybutt +6 more

Intestinal neuropod cell GUCY2C regulates visceral pain

Journal of Clinical Investigation(2022)10.1172/jci165578

N/A

0DataRank · unranked

24 citations

Annie K. Londregran, Tyler D. Alexander, Ariana A. Entezari, Shely Bar-Ad, Lan Cheng +5 more

T-Cell Responses to Immunodominant Listeria Epitopes Limit Vaccine-Directed Responses to the Colorectal Cancer Antigen, Guanylyl Cyclase C

Frontiers in Immunology(2022)10.3389/fimmu.2022.855759

N/A

0DataRank · unranked

18 citations

Jagmohan Singh, Yanki Yarman, Robert D. Carlson, Joshua R. Barton, Scott A. Waldman +2 more

Emerging drug targets for colon cancer: A preclinical assessment

Expert Opinion on Therapeutic Targets(2022)10.1080/14728222.2022.2039119

N/A

0DataRank · unranked

14 citations

Trevor R. Baybutt, Jessica Kopenhaver, Adam E. Snook, Scott A. Waldman, Madison Crutcher

Biomarkers in the development of individualized treatment regimens for colorectal cancer

Frontiers in Medicine(2022)10.3389/fmed.2022.1062423

N/A

0DataRank · unranked

14 citations

Scott A. Waldman, Madison Crutcher

Guanylyl Cyclase C as a Diagnostic and Therapeutic Target in Colorectal Cancer

Personalized Medicine(2022)10.2217/pme-2022-0026

N/A

0DataRank · unranked

7 citations

Ariana A. Entezari, Madison Crutcher, Adam E. Snook, Scott A. Waldman, Adi Caspi

Overview of predictive and prognostic biomarkers and their importance in developing a clinical pharmacology treatment plan in colorectal cancer patients

Expert Review of Clinical Pharmacology(2022)10.1080/17512433.2022.2138339

N/A

0DataRank · unranked

1 citations

Adam E. Snook, Scott A. Waldman, Madison Crutcher

Enteroendocrine cell regulation of the gut-brain axis

Frontiers in Neuroscience(2023)10.3389/fnins.2023.1272955

N/A

0DataRank · unranked

67 citations

Anne Londregan, Tyler D. Alexander, Ariana A. Entezari, Manuel Covarrubias, Scott A. Waldman +1 more

Fundamental Neurochemistry Review: The role of enteroendocrine cells in visceral pain

Journal of Neurochemistry(2023)10.1111/jnc.16022

N/A

0DataRank · unranked

8 citations

Tyler D. Alexander, Manuel Covarrubias, Scott A. Waldman, Anne Londregan

GUCY2C signaling limits dopaminergic neuron vulnerability to toxic insults

Research Square(2023)10.21203/rs.3.rs-3416338/v1

N/A

0DataRank · unranked

1 citations

Lara Cheslow, Matthew Byrne, Jessica Kopenhaver, Lorraine Iacovitti, Richard J. Smeyne +2 more

Biomarkers for Managing Neurodegenerative Diseases

Biomolecules(2024)10.3390/biom14040398

N/A

0DataRank · unranked

22 citations

Adam E. Snook, Scott A. Waldman, Lara Cheslow

CD8α Structural Domains Enhance GUCY2C CAR-T Cell Efficacy

Cancer Biology & Therapy(2024)10.1080/15384047.2024.2398801

N/A

0DataRank · unranked

9 citations

Ariana A. Entezari, Adi Caspi, Ross E. Staudt, Robert D. Carlson, Scott A. Waldman +2 more

GUCY2C signaling limits dopaminergic neuron vulnerability to toxic insults

npj Parkinson s Disease(2024)10.1038/s41531-024-00697-z

N/A

0DataRank · unranked

7 citations

Matthew Byrne, Jessica Kopenhaver, Lorraine Iacovitti, Richard J. Smeyne, Adam E. Snook +2 more

Biomarkers for Managing Neurodegenerative Diseases

The Medicine Forum(2024)10.20944/preprints202403.0247.v1

N/A

0DataRank · unranked

11 citations

Adam E. Snook, Scott A. Waldman, Lara Cheslow

Aqueous humor biomarkers in ocular oncology: Insights and advances

Cell Reports Medicine(2025)10.1016/j.xcrm.2025.102447

N/A

0DataRank · unranked

4 citations

Signe Caksa, Rachel E Cain, Scott A. Waldman, Andrew E. Aplin, Lara Cheslow

Immunotherapy for precision medicine in colorectal cancer

Expert Review of Precision Medicine and Drug Development(2025)10.1080/23808993.2025.2560303

N/A

0DataRank · unranked

2 citations

Michael Xu, Zinah A Bairmani, Babar Bashir, Scott A. Waldman, Adam E. Snook +1 more

Universal solid tumor therapy with CD5-deleted, DSG2-directed CAR-T cells.

Journal of Clinical Oncology(2025)10.1200/jco.2025.43.16_suppl.2539

N/A

0DataRank · unranked

0 citations

Lindsay Weil, Trevor R. Baybutt, Ozlem Kulak, Miao Cao, Ross E. Staudt +15 more